Co-Diagnostics, Inc. Total Liabilities and Equity
Co-Diagnostics, Inc. (CODX) had Total Liabilities and Equity of $16.59 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $16.59M.
- 2026-03-31: Liabilities and Equity $21.50M.
- 2025-12-31: Liabilities and Equity $24.74M.
- 2025-09-30: Liabilities and Equity $44.74M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $16.59M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $21.50M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $24.74M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $44.74M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $46.47M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $55.15M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $63.56M 10-K · filed 2026-03-31 | $64.00M 10-K · filed 2025-03-27 |
| 2024-09-30 | $72.38M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $80.70M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $86.67M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $95.32M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $108.68M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $112.80M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $117.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $123.09M 10-K · filed 2024-03-14 | $123.09M 10-K · filed 2023-03-16 |
| 2022-09-30 | $147.84M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $160.84M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $171.15M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $160.03M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $105.36M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $92.79M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $81.12M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $71.24M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $54.65M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $38.79M 10-Q/A · filed 2020-11-03 | $36.42M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $20.48M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $2.22M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $3.81M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.32M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $6.12M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.55M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $2.71M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.97M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $3.33M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $4.66M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $6.05M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $467.58K 10-Q · filed 2017-08-25 | |
| 2016-12-31 | $1.30M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |